Psoriasis: An overview and update

Nurse Practitioner

Volumn 40, Issue 3, 2015, Pages 23-26

  Limaye, Karen ^a  

^a Mystic Valley Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; NURSE PRACTITIONER; NURSING; NURSING DIAGNOSIS; PSORIASIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NURSE PRACTITIONERS; NURSING DIAGNOSIS; PSORIASIS;

EID: 84927566295     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000453651.30695.43     Document Type: Review

References (14)

1. National Health and Nutrition Examination Survey Data. National Center for Health Statistics. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009-2010.
2. Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol. 2014;70(1):146-167.
3. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh: Mosby; 2010.
4. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654-662.
5. Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014-1024.
6. Orgaz-Molina J, Magro-Checa C, Rosales-Alexander JL, et al. Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis. J Am Acad Dermatol. 2013;69(6):938-946.
7. National Psoriasis Foundation. The Psoriasis and Psoriatic Arthritis Pocket Guide. Portland, OR; 2009.
8. Hajdarbegovic E, Nijsten T, Westgeest A, Habraken F, Hollestein L, Thio B. Decreased prevalence of atopic features in patients with psoriatic arthritis, but not in psoriasis vulgaris. J Am Acad Dermatol. 2013;68(2):270-277.
9. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137-174.
10. Kalb RE, Bagel J, Korman NJ, et al. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60(1):120-124.
11. American Academy of Dermatology Board of Directors. Position Statement on Treatment of Psoriatic Patients. 2013. http://www.aad.org/Forms/Policies/Uploads/PS/PS%20on%20 Treatment%20of%20Psoriatic%20Patients.pdf.
12. Doherty SD, Van Voorhees A, Lebwohl MG, Korman NJ, Young MS, Hsu S. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. J Am Acad Dermatol. 2008;59(2):209-217.
13. Hugh J, Van Voorhees AS, Nijhawan RI, et al. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014;70(1):168-177.
14. Wine-Lee L, Keller SC, Wilck MB, Gluckman SJ, Van Voorhees AS. From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. J Am Acad Dermatol. 2013;69(6):1003-1013.